Investigational Drug Information for BMS-986165
✉ Email this page to a colleague
What is the development status for investigational drug BMS-986165?
BMS-986165 is an investigational drug.
There have been 48 clinical trials for BMS-986165.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 30th 2023.
The most common disease conditions in clinical trials are Psoriasis, Lupus Erythematosus, Systemic, and Arthritis, Psoriatic. The leading clinical trial sponsors are Bristol-Myers Squibb, Covance, and [disabled in preview].
There are two US patents protecting this investigational drug and fifty-nine international patents.
Summary for BMS-986165
| US Patents | 2 |
| International Patents | 59 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2023-01-30) |
| Vendors | 32 |
Recent Clinical Trials for BMS-986165
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting | Bristol-Myers Squibb | Phase 4 |
| A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus | Bristol-Myers Squibb | Phase 3 |
| A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata | Bristol-Myers Squibb | Phase 2 |
Clinical Trial Summary for BMS-986165
Top disease conditions for BMS-986165
Top clinical trial sponsors for BMS-986165
US Patents for BMS-986165
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BMS-986165 | ⤷ Try a Trial | ⤷ Try a Trial | ||
| BMS-986165 | ⤷ Try a Trial | ⤷ Try a Trial | ||
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BMS-986165
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BMS-986165 | Argentina | AR094452 | 2032-11-08 | ⤷ Try a Trial |
| BMS-986165 | Australia | AU2013341186 | 2032-11-08 | ⤷ Try a Trial |
| BMS-986165 | Australia | AU2017201076 | 2032-11-08 | ⤷ Try a Trial |
| BMS-986165 | Australia | AU2018267545 | 2032-11-08 | ⤷ Try a Trial |
| BMS-986165 | Australia | AU2020203967 | 2032-11-08 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
